| A
new segment with high prospects, we associate with a USFDA certified
facility for finished product . With backward integration for production
of the Raw Material as well products are suitable placed for world
markets. Our vision is to make cost effective quality products reach
the world markets. |
| Products
|
|
| rTNK
tPA [ rTNK-issue Plasminogen Activator ] |
| Generic
name : Tenecteplase; produced from recombinant CHO cells. |
| Indication
: acute myocardial infarction |
| Product
presentation : lyophilised vial in 30 mg, 40 mg and 52.5 mg doses |
|
|
| Granulocyte
Macrophage Colong Stimulating Factor ( rHuGM-CSF ) |
| Generic
Name : Sargramostim produced in yeast ( pichia) |
| Indication
: Chemotherapy indused neutropoenia |
| Product
Presentation lyophilised vial of 300,400,500 mcg doses. |
|
| Erythropoietin
( rHu-EPO ) as per Ph EUR. |
| Indications
- anemia in patients with rela failure and chemotherapy |
| Product
Presentation : Prefilled syringes and vials of 2000 ie, 3000 iu, 4000
i.u, 6000 iu, 10000 iu. 20,000 iu and 40,000 i.u. |
| |
| Product
Pipeline |
| G--CSF
|
| Peg.
G-CSF |
| Peg.
Interferon @ 2 B. |
| Finished
formulations as well as Raw Material is available for sale with relevent
documentation for registration |
| |
|